4//SEC Filing
Fitzpatrick Alexander A 4
Accession 0001415889-25-014186
CIK 0001671858other
Filed
May 21, 8:00 PM ET
Accepted
May 22, 5:00 PM ET
Size
9.0 KB
Accession
0001415889-25-014186
Insider Transaction Report
Form 4
Fitzpatrick Alexander A
Chief Legal Officer
Transactions
- Sale
Common Stock
2025-05-20$14.10/sh−102,969$1,451,513→ 89,613 total - Exercise/Conversion
Common Stock
2025-05-20$5.58/sh+100,000$558,000→ 192,582 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-05-20−100,000→ 200,000 totalExercise: $5.58Exp: 2034-01-01→ Common Stock (100,000 underlying)
Footnotes (3)
- [F1]Includes 3,355 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan on December 31, 2024.
- [F2]The weighted average sale price for the transaction reported was $14.0966 and the range of prices were between $14.02 and $14.25. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F3]25% of the shares subject to the option vested on January 1, 2025, and the remaining shares will vest monthly thereafter over three years.
Documents
Issuer
ARS Pharmaceuticals, Inc.
CIK 0001671858
Entity typeother
Related Parties
1- filerCIK 0001398595
Filing Metadata
- Form type
- 4
- Filed
- May 21, 8:00 PM ET
- Accepted
- May 22, 5:00 PM ET
- Size
- 9.0 KB